AtriCure - Stock Price History | ATRC
Historical daily share price chart and data for AtriCure since 2020 adjusted for splits. The latest closing stock price for AtriCure as of February 21, 2020 is 39.41.
- The all-time high AtriCure stock closing price was 43.84 on February 14, 2020.
- The AtriCure 52-week high stock price is 44.51, which is 12.9% above the current share price.
- The AtriCure 52-week low stock price is 22.57, which is 42.7% below the current share price.
- The average AtriCure stock price for the last 52 weeks is 30.08.
| AtriCure Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 29.1289 | 30.2500 | 33.3400 | 23.8100 | 32.5100 | 6.24% |
| 2018 | 26.1470 | 18.4700 | 35.5800 | 15.0500 | 30.6000 | 67.76% |
| 2017 | 20.3076 | 19.2000 | 24.8800 | 14.9400 | 18.2400 | -6.80% |
| 2016 | 16.5649 | 21.1600 | 21.4700 | 13.5400 | 19.5700 | -12.79% |
| 2015 | 21.8535 | 19.7800 | 27.9300 | 17.4000 | 22.4400 | 12.42% |
| 2014 | 17.5247 | 18.0300 | 22.1800 | 13.6400 | 19.9600 | 6.85% |
| 2013 | 10.3316 | 7.1400 | 18.9300 | 7.1400 | 18.6800 | 170.72% |
| 2012 | 8.5684 | 11.7400 | 11.9600 | 5.9100 | 6.9000 | -37.84% |
| 2011 | 11.4511 | 10.2500 | 14.5000 | 8.5400 | 11.1000 | 8.08% |
| 2010 | 6.7755 | 5.6500 | 10.2700 | 4.5600 | 10.2700 | 70.03% |
| 2009 | 3.2447 | 2.2000 | 6.0500 | 1.0700 | 6.0400 | 172.07% |
| 2008 | 9.7793 | 13.2400 | 14.0500 | 2.0000 | 2.2200 | -83.07% |
| 2007 | 10.6159 | 9.1500 | 13.5900 | 8.4400 | 13.1100 | 46.64% |
| 2006 | 8.1361 | 10.7900 | 11.8000 | 5.4400 | 8.9400 | -16.06% |
| 2005 | 13.1674 | 14.0800 | 14.9500 | 10.6500 | 10.6500 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.610B | $0.231B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $156.438B | 27.30 |
| Medtronic (MDT) | Ireland | $152.615B | 20.51 |
| Stryker (SYK) | United States | $84.081B | 27.18 |
| Boston Scientific (BSX) | United States | $59.238B | 26.73 |
| Baxter (BAX) | United States | $47.512B | 28.81 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.568B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $32.578B | 20.13 |
| Lonza Group Ag (LZAGY) | Switzerland | $31.806B | 0.00 |
| Coloplast (CLPBY) | Denmark | $30.478B | 47.03 |
| Terumo (TRUMY) | Japan | $26.454B | 33.01 |
| ResMed (RMD) | United States | $25.453B | 44.22 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $22.585B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $18.226B | 0.00 |
| Insulet (PODD) | United States | $13.381B | 636.59 |
| Bio-Rad Laboratories (BIO) | United States | $12.245B | 57.21 |
| Perrigo (PRGO) | Ireland | $8.113B | 15.13 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.794B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.537B | 38.94 |
| Hill-Rom Holdings (HRC) | United States | $7.179B | 20.65 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.161B | 0.00 |
| Haemonetics (HAE) | United States | $6.009B | 36.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| ICU Medical (ICUI) | United States | $4.452B | 29.02 |
| Envista Holdings (NVST) | United States | $4.387B | 0.00 |
| NuVasive (NUVA) | United States | $4.110B | 31.84 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.971B | 0.00 |
| Neogen (NEOG) | United States | $3.791B | 63.10 |
| Agios Pharmaceuticals (AGIO) | United States | $3.678B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.661B | 0.00 |
| Quidel (QDEL) | United States | $3.398B | 29.83 |
| National Vision Holdings (EYE) | United States | $2.856B | 64.46 |
| Aurora Cannabis (ACB) | Canada | $1.964B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.575B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.501B | 0.00 |
| InMode (INMD) | Israel | $1.278B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.190B | 0.00 |
| Aphria (APHA) | $1.137B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.085B | 21.45 |
| VAREX IMAGING (VREX) | United States | $0.991B | 20.59 |
| PetIQ (PETQ) | United States | $0.988B | 24.10 |
| Cerus (CERS) | United States | $0.860B | 0.00 |
| Quanterix (QTRX) | United States | $0.796B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.715B | 27.38 |
| Omeros (OMER) | United States | $0.674B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.650B | 16.25 |
| LeMaitre Vascular (LMAT) | United States | $0.615B | 34.93 |
| MacroGenics (MGNX) | United States | $0.563B | 0.00 |
| Surmodics (SRDX) | United States | $0.509B | 58.52 |
| Owens & Minor (OMI) | United States | $0.449B | 16.63 |
| Organigram Holdings (OGI) | Canada | $0.438B | 0.00 |
| HEXO (HEXO) | $0.409B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.378B | 47.15 |
| Zynex (ZYXI) | United States | $0.360B | 40.67 |
| Utah Medical Products (UTMD) | United States | $0.358B | 25.42 |
| Meridian Bioscience (VIVO) | United States | $0.339B | 13.64 |
| BioLife Solutions (BLFS) | United States | $0.332B | 135.08 |
| Female Health (VERU) | United States | $0.299B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.287B | 0.00 |
| Bovie Medical (APYX) | United States | $0.259B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.233B | 1175.00 |
| Viemed Healthcare (VMD) | United States | $0.217B | 22.92 |
| Rockwell Medical (RMTI) | United States | $0.205B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.202B | 0.00 |
| Vapotherm (VAPO) | United States | $0.198B | 0.00 |
| United Health Products (UEEC) | United States | $0.187B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.179B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.174B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.131B | 9.54 |
| Chimerix (CMRX) | United States | $0.106B | 0.00 |
| Surface Oncology (SURF) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.084B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 20.29 |
| MTech Acquisition (KERN) | United States | $0.077B | 0.00 |
| Nephros (NEPH) | United States | $0.071B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.068B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.031B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.023B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.023B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| Myomo (MYO) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
